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In  a  previous study  1 it was found that vaccination of a  group of 
mice did not protect  all  the individual animals against subsequent 
infection with Type II pneumococci.  The protection obtained was 
irregular; some individuals resisted relatively large numbers of pneu- 
mococci, while other individuals succumbed to much smaller doses. 
The  present  paper  deals  with  a  further  study of  the  infection of 
individual  mice  after  vaccination  against  Type  II  pneumococci. 
The experiments were planned to determine the relative importance of 
two factors in the postvaccination infections: the previous immunity 
response of the individual animals, and  the dosage of the invading 
bacteria.  The factor of differences in the immunity response of the 
individual is made especially prominent, for the animals (mice)  not 
only possess no demonstrable natural immunity to the specific bacteria 
(pneumococci) but the vaccination was done with a type of Pneumo- 
coccus known not to produce a highly effective antibacterial serum. 
EXPERIMENTAL. 
Methods. 
Immunization.--70  line-bred females, between 3 and 4 months old, which had 
been separated from males since weaning  were selected for immunization. 
The organisms from a 10 hour broth culture of Type II pneumococci (Strain 
D39, Hospital of The Rockefeller  Institute) were resuspended in salt solution and 
heated at 60°C. for 30 minutes.  Each mouse received, subcutaneously, 0.5 cc. of a 
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diluted suspension  of the vaccine (equivalent to 0.1  cc. of broth culture)  every 
2 days for six doses.  10 days after the last injection a number of mice were tested 
for acquired immunity.  The remainder were given a second course of immuniza- 
tions with freshly prepared vaccine at 2 day intervals for five doses.  After a rest 
period of 10 days, a number of animals were tested for immunity and the remainder 
were given a third course of immunizations with fresh vaccine exactly as in the 
second course; these animals were also tested for acquired immunity 10 days after 
the last injection. 
A number of mice died during the period of immunization, and others were 
eliminated from the tests because of evident poor condition. 
Tests of Immunity of the Animals (Protection Tests).--The  tests of immunity of 
the vaccinated animals were made by intraperitoneal injections of 0.5 cc. of broth 
containing the desired amount of a  10 hour broth culture of the same virulent 
strain as that from which the vaccine had been prepared. 
Experiments  I,  2,  and  3:  Influence  of Size  of Dose upon  Infection: 
Active Immunity Tests of Vaccinated Mice by Injection  of 
Different Numbers of Bacteria. 
The first series of experiments (Experiments  1,  2,  and 3)  consisted 
of tests of the influence of size of dose upon the occurrence of infections 
in groups of mice which had previously received vaccination against 
Type II pneumococci.  The doses used in these active immunity tests 
were  10 -6,  10 -5,  10 -4,  and  10 -3 cc. of broth  culture of pneumococci; 
this  range  of  doses  includes  the  numbers  of  pneumococci  against 
which passive protection is usually effective.  The mice used in Ex- 
periment  1  had  received  one  course  of  vaccination  before  the  im- 
munity tests;  the animals used in Experiments 2 and 3 had received, 
respectively,  two  and  three  courses.  The purposes of the investiga- 
tion  are met by presenting  the  three  experiments  collectively,  since 
each  animal  had  received  the  same  immunization  treatment as the 
other  individuals  used  in  the  same  experiment.  The  results  of 
of Experiments 1, 2, and 3 are presented in Table I; a summary of these 
results is collected in Table II. 
Injections and Virulence Controls.--The vaccinated mice were injected as de- 
scribed under "Methods."  The normal mice which  were injected for virulence 
controls invariably succumbed to all amounts of culture tested--/.e., from 10 -7 cc. 
to 10 -a cc.  The results of the virulence controls are presented collectively in the 
last column of Table  I. 
Control of Possible Effect of Weight of Individual Animals.--All  the mice used in j.  M.  NEILL  AND  E.  L.  GASPARI 
TABLE  I. 
Tests of the Active Immunity of Vaccinated Mice. 
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Amount culture 
injected 
C¢° 
10-s 
10  ~ 
I0  ~ 
lO-S 
10-v 
Experiment l. 
Immunity tests on 
first group 
of mice (after one 
course of 
vaccinations) 
Experiment 2. 
Immunity tests on 
second group 
of mice (after two 
courses of 
vaccinations) 
D  24-48 hrs. 
S  5 days 
D  24-48 hrs. 
S  5 days 
D  24-48 hrs. 
S  5 days 
D  24-48 hrs. 
S  5 days 
No tests 
D  24-48hrs. 
D  24-48hrs. 
D  24-48hrs. 
D  48--72  hrs. 
S  5 days 
S  5 days 
D  24-48 hrs. 
D  24-48 hrs. 
S  5 days 
S  5 days 
S  S days 
S  5 days 
No tests 
Experiment 3. 
Immunity tests on 
third group 
of mice (after three 
courses of 
vaccinations) 
D  24-48 hrs. 
D  24-48 hrs. 
D  24-48 hrs. 
D  24-48 hrs. 
D  48-72 hrs. 
S  5 days 
S  5 days 
D  48-72  hrs. 
D  48-72  hrs. 
D  48-72  hrs. 
D  48-72  hrs. 
D  48-72  hrs. 
D  48-72  hrs. 
S  5 days 
D  24-48 hrs. 
D  48-72 hrs. 
D  48-72 hrs. 
D  48-72 hrs. 
D  48-72 hrs. 
S  5 days 
S  5 days 
D  24-48 hrs. 
D  24--48  hrs. 
D  24-48 hrs. 
D  48-72 hrs. 
D  48-72 hrs. 
D  48-72 hrs. 
S  5 days 
No tests 
Virulence controls* 
(non-immunlzed 
mice) on 
Experiments 1, 2, 3 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-?2 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  24-72 hrs. 
D  ffi died of pneumococcus septicemia. 
S  -- survived. 
* Presented in composite form; duplicate mice were injected with each amount 
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the experiments were in excellent physical  condition but varied in weight from 
24 to 31 gm.  To rule out any possible influence of weight upon the resistance to 
infection,  the mice of different weights in Experiments 2 and 3 were matched so 
that the tests of the different amounts of culture were made with a series of ani- 
mals of comparable weight.  The results showed that  there was no correlation 
between weight of the animal and its susceptibility. 
Surdval in Table/.--Since all the virulence controls died in less  than 72 hours 
after injection the protection of the vaccinated mice is based upon  survival for 
5 days after the  test injection.  Three of the mice reported as  "Survived" in 
Table I died between 10 and 14 days after injection. 
The most obvious fact in Table I  is the irregularity in the  survival 
and death of the  vaccinated mice.  In each of the three experiments 
individual  mice were infected by doses smaller than  the doses which 
TABLE II. 
Summary of Tests for Active Immunity of All the Vaccinated Mice." Proportion of 
Animals Protected against Different Doses of P~eumococci. 
Amount of culture  Number of vaccinated  Number of mice  Proportion of mice 
injected,  mice tested  protected  protected 
CC. 
10-3 
10-4 
10-5 
10-~ 
10  -6 to  10 -6 
12 
12 
12 
12 
48 
3 
4 
4 
5 
16 
per cent 
25 
33 
33 
42 
33 
other mice survived and vice versa.  This lack of relationship between 
the  number  of  pneumococci  injected  and  the  infection  of  the  vac- 
cinated  animals  is  emphasized  in  the  summary  of  the  experiments 
given in  Table II.  There it is seen that  about  the same proportion 
of the vaccinated mice survived the injection of each of the different 
doses; in fact, any deviation from the average proportion of one-third 
survivors represents the  survival or death of only one mouse. 
Since  these  facts  indicate  that  within  this  range of  dosage  (10 -8 
to 10 -3 cc.)  the size of the dose does not influence the infection of the 
vaccinated  animals,  the  infection  or  resistance  of individuals  would 
logically  be  attributed  to  differences  in  individual  immunity.  In 
these  experiments  the  immunity of  the  animals was limited  to  that J. M. NEILL  AND  E. L. GASPARI  I17 
acquired by vaccination.  Therefore, within the range of dosage used 
in  these  experiments,  the  previous immunity response of the  indi- 
vidual  appeared  to  be  the  factor determining  the  postvaccination 
infections. 
Obtaining a "Selected Group"  o/Actively Immune Mice. 
The preceding  results  indicated  that  only a  certain proportion of the  mice 
respond effectively  to pneumococcus  (Type II) vaccine.  This fact made it im- 
possible  to carry out additional experiments until we obtained a selected group of 
vaccinated mice.  It seemed that a "selected  group" of individuals known to pos- 
sess an effective active immunity could  be obtained by collecting  all  the mice 
which had survived the previous  injections  of live bacteria in Experiments  1, 2, 
and 3.  These mice were given the following additional vaccination treatment. 
Survivors of Experiment 1A.--10 days after the injection made in Experiment  1, 
all the surviving  mice were put upon a vaccination schedule similar  to that de- 
scribed under "Methods;" in addition  to the immunization  preceding the tests of 
Experiment  1,  they received  three vaccination courses  of five injections  each. 
Survivors of Experiment 2.4 .--These mice received, in addition to the immuniza- 
tion preceding the tests of Experiment  2, two courses of the described vaccination. 
Surz~vors o/ Experiment 3A .--These received one additional course of vaccinations. 
A few mice died during the immunization period. 
These mice represent  a "selected group" of animals known by previous tests to 
possess some degree of active immunity against Type II pneumococci and were 
used as described in the following experiments. 
Occurrence  of True Mass Infection in Actively Immune Mice. 
It is an established  fact that no amount of antipneumococcus  serum can pas- 
sively protect mice against overwhelmingly  large  numbers  of virulent pneumo- 
cocci.  This phenomenon can properly be termed "true" mass infection, in that the 
passive immunity furnished  by the antibacterial serum is known to be sufficient 
to protect against infection  by smaller  numbers  of the bacteria.  Experiments 
were made to determine  whether active immunity likewise fails when  the vac- 
cinated animal is invaded by doses beyond the zone within which passive protection 
is effective.  In view of the previously  demonstrated differences in the response 
of individual  mice  to vaccination,  the  tests  for  "mass  infection"  were limited 
to animals known to have acquired  sufficient active immunity to resist invasion 
by smaller numbers of pneumococci. 
Four mice from the previously  described  "selected  group" of actively immune 
mice were injected with 0.02 cc. of broth culture  of Type II pneumococci.  Al- 
though these mice possessed a fairly high degree of antipneumococcus  active im- 
munity, they all died of pneumococcus septicemia.  (That all of them possessed 118  VACCINATION  WITH  TYPE  II  PNEUMOCOCCI 
at that time sufficient immunity to protect them against at least 10 4  cc. of broth 
culture is shown by the fact that all other individuals of the "selected" group sur- 
vived that dosage when tested in a simultaneous experiment.) 
The  results  of  this  experiment  showed  that,  even  in  a  selected 
group of actively immune mice, infection invariably follows invasion 
by overwhelmingly large numbers of pneumococci regardless of the 
previous  immunity  response  of  the  individual.  This  experiment 
presents a  definitely controlled example of the true mass infection of 
actively  immunized  animals,  in  that  the  infected  individuals  were 
known to possess sufficient immunity to protect them against smaller 
numbers of pneumococci. 
Comparison of the Occurrence of Infections in an "Unselected" and in a 
"Selected" Group of Vaccinated Mice When All the Individuals 
Are  Injected  with  the  Same  Number  of  Pneumococd 
(Type II). 
The importance of the factor of individual  immunity  response  in 
postvaccination  infection  was  further  illustrated  by  the  following 
comparison  of  the  percentage  of  infections  which  occur  when  a 
constant number of bacteria is injected into  two different groups of 
vaccinated  mice. 
In  one  group,  the  factor  of  differences  in  individual  immunity 
response was eliminated by including only animals known by previous 
test  to have  sufficient immunity  to  resist  the invasion of at least a 
small  number  of pneumococci;  in  the  other  group,  this  factor was 
uncontrolled  (as in  Experiments  1,  2,  and  3),  and  although  all  the 
animals  had  received  the  same vaccinations,  no  previous  tests  had 
been made to determine  the effectiveness of their immunity response. 
The same number of pneumococci was injected into each  individual 
animal;  the dose employed (10-* cc. of broth culture)  was below  the 
zone of true mass infection. 
The tests were carried out with the following  three groups of mice: 
1. The "selected" group of vaccinated animals which had been found in pre- 
vious tests to have sufficient active immunity to resist infection against at least 
a small number of Type II pneumococci.  These mice had received the vaccina- 
tion treatment  indicated in the preceding description of the procedure employed 
in obtaining the "selected population."  (In addition to the heat-killed vaccine, .]'.  M.  NEILL  AND  E.  L.  GASPARI  119 
they had received an injection of living bacteria in connection with Experiment 
1, 2,  or 3.) 
Five mice from this group were inoculated with the test dose. 
2.  The "unselected" group of vaccinated animals which,  although vaccinated, 
had never been tested to see whether or not they had developed any immunity. 
(This group is analogous in this respect to the animals used in Experiments 1, 2, 
and 3.)  The routine of immunization was the same as that described previously 
under "Methods," with the exception that the mice in this group received one 
additional course of vaccinations. 
Nine mice from this group were inoculated with the test dose. 
3.  A group of normal animals was included to furnish evidence of the invari- 
ability of infection of non-vaccinated mice when invaded by the  test dose of 
TABLE  III. 
Occurrence of Infection in a "Selected" and "Unselected" Group of Vaccinated Mice 
When Injected with the Same Dose of Type II Pneumococci. 
Groups  of  mice  tested 
Vaccinated mice 
Normal  (not vac- 
cinated)  mice 
"Selected"  group  (individuals 
previously tested for acquired 
immunity) 
"Unselected" group (individuals 
not  previously  tested  for  ac- 
quired immunity) 
"Selected" group  (animals  posses- 
sing  no  natural  immunity) 
Number 
of animals 
injected 
----T- 
9 
6 
Number 
survived  --;--- 
2 
0 
Percentage 
of animals 
protected 
100 
22 
bacteria.  Six mice received the test dose of 10 -4 cc.; in addition, the usual dupli- 
cate virulence controls were made with 10  -~, 10 -s, l0 -~ cc. of culture. 
The results of the experiment are summarized in Table III. 
The results of this experiment (Table III) furnish further  evidence 
of  the  importance  of  the  previous  immunity  response  of  the indi- 
vidual  in  the  determination  of  the  occurrence  of  the  postvacci- 
nation  infections.  The  two  groups  of  vaccinated  mice,  although 
they  had  received  approximately  the  same  previous  immunization 
treatment,  represent  respectively,  an  "unselected"  and  a  "selected 
population."  In  the  "selected"  group  where  the  factor  of marked 
differences in individual immunity response had been eliminated,  the 
protection  was  regular  and  no  infections  occurred  On  the  other 120  VACCINATION WITH TYPE II  PNEUMOCOCCI 
hand, in the "unselected"  group (where the actual immunity response 
of the vaccinated  animals  had  not  been  tested)  some mice were in- 
fected and  some were not,  in  spite of the  fact  that  each individual 
was  known  to  have  been  invaded  by  the  same,  reasonably  small 
number of bacteria.  Whether or not infection occurred in  the "un- 
selected" group probably depended upon the response of the respective 
individuals to the previous vaccination. 
The chief interest of these results is due to the fact that two factors 
were controlled which are impossible to control in bacterial infections 
outside the laboratory: (1)  dosage  or  numbers  of the invading bac- 
teria; (2)  differences in individual immunity response to the vaccina- 
tion.  When the first of these two factors is constant,  the occurrence 
of the infection depends upon the second factor, and the percentage of 
infection within  the  group  depends  upon  the  percentage of  the  in- 
dividuals that had previously responded effectively to the vaccination. 
When the second factor is kept constant  (as in the "selected popula- 
tion" of known immunes)  the occurrence of infection  depends upon 
the numbers of bacteria,  and  all the individuals are protected  if  the 
dosage is kept below the zone of true mass infection. 
Type Specificity of Active Immunity of Mice  Vaccinated with 
Type II Pneumococci. 
The type specificity of the active immunity of mice vaccinated with Type II 
pneumococci  was  tested as follows: Four mice  were  taken from the described 
"selected population" of Type II-immune individuals and injected respectively 
with one of the following amounts of virulent Type I organisms,  10  -~, 10 -4, 10 -5, 
10  -6 cc. of broth culture.  (That the animals actually possessed active immunity 
toward the homologous pneumococci  (Type II) was controlled by simultaneous 
tests of the homologous protection of other individuals  from this "selected" group 
of mice.)  Duplicate normal animals  were injected with  the same  amounts to 
serve as virulence controls of the culture. 
The mice which possessed a high degree of active immunity to Type II pneu- 
mococci died at approximately the same time as did the normal (unvaccinated) 
animals,  and  thus  showed  no evidence of immunity against  the  heterologous 
(Type I) pneumococci.  This experiment is of interest as evidence that antlpneu- 
mocoecus  (Type II) active immunity of mice is just as type-specific as the im- 
munity in passive protection tests. j.  M.  NEILL  AND  E.  L.  GASPARI  121 
DISCUSSION. 
The preceding experiments have dealt with the relative value of 
dosage and individual immunity response as factors in the infection 
of mice  which had previously been vaccinated with Type II pneumo- 
cocci.  After the completion of vaccination the resistance of the in- 
dividuals was tested by the intraperitoneal injection of different doses 
of live bacteria.  The results of the tests of active immunity can be 
analyzed to best advantage according to two zones of dosage. 
In the first zone (between 10 -s and 10 -3 cc. of broth culture) the 
infection or protection of the vaccinated animals was irregular, and 
certain individuals succumbed  to doses  much smaller  than those which 
other individuals resisted.  The differences  in  the  number of live 
bacteria  injected within  this  zone seemed to  be  entirely without 
influence in  the determination of infection or protection since the 
percentage occurrence  of infection was approximately the same in the 
groups injected with each of the different  doses although the maximum 
dose (10 -3 cc.) was I000 times  the minimum dose (I0 -s cc.) employed 
in the experiments.  This  apparent absence of any relation between 
size of dose and infection indicates that the irregularities in infection 
and protection are due to differences  in the immunity of the individ- 
uals.  Since  the mice possessed no demonstrable natural immunity 
to the specific  bacteria, the differences  in the degree acquired must 
be referred to differences  in individual response to the same vaccina- 
tion.  Hence,  in this zone of dosage (i0  -6 to I0  -3 cc. of culture), the 
occurrence of postvaccination infection was determined by the  lack 
of previous immunity response of the individual rather than by the 
numbers of the invading bacteria. 
In the second zone of dosage, the relations were reversed and the 
injection of overwhelming  numbers of the bacteria invariably resulted 
in infection in spite of the fact that the animals were known to possess 
a fairly high degree of active immunity.  The infection of the mice 
tested in these controlled experiments can properly be termed true 
"mass infection;" but it is well to recognize that the same term is 
often  applied to  postvaccination infections where the  actual  im- 
munity of the individual is as unknown as is the dosage. 
The above demonstration of the relative value of these  two factors 122  VACCINATION  WITH  TYPE  II  PNEUMOCOCCI 
in the infection of mice after vaccination with Type II pneumococci 
is of some interest in  the question of postvaccination infections in 
general.  In our experiments, the factor of differences in individual 
response to the vaccination was made especially prominent by choos- 
ing  animals  possessing  no  demonstrable  natural  immunity  and 
vaccinating them with a  type of Pneumococcus known not to give a 
high  degree  of  passive  immunity.  However,  the  same  factor  is 
probably involved, if much less prominently, in the effectiveness of 
the vaccination of other animals against other bacteria.  The failure 
of one attack of typhoid fever to render certain individuals immune 
must be evidence of differences in the immunity response of men  to 
typhoid bacilli.  Variations in  the passive protective value of con- 
valescent serum from pneumonia and other diseases probably repre- 
sent examples of the same phenomenon. 
SUMMARY. 
A group of mice was vaccinated against Type II pneumoccci and 
subsequently tested for  immunity against  different numbers of the 
live bacteria.  The immunity tests were conducted within two zones 
of dosage.  In the first zone where the doses were kept within reason- 
able  limits  (10  -6  to  10  -~  cc.  of  culture),  the  number of  invading 
bacteria was without influence and the occurrence of infections was 
determined by  the  previous  immunity response of  the  individual. 
In the second zone of dosage (where passive protection also  fails), 
these relations were reversed, and invasion by overwhelming numbers 
of the bacteria invariably produced infection regardless of the previous 
immunity response of the individual. 
These results present an extreme example of the importance of the 
immunity response of the individual as a  factor always concerned in 
the effectiveness of vaccination. 